SPDR S&P Biotech ETF Rating $84.85 -0.58 (-0.68%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.67Holdings in XBI have an aggregate rating of Moderate Buy based on 471 analyst ratings issued in the past year covering 25 companies (56.4% of the portfolio).XBI Aggregate Price Target$85.580.45% UpsideHigh Prediction$85.58Average Prediction$85.58Low Prediction$85.58Holdings in XBI have an aggregate price target of $85.58 and a range of $85.58 to $85.58 covering 25 companies (56.4% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.72%MRNAModerna$25.45-2.6%4.4716 of 5 stars2.04$43.59 71.3%242.60%ALNYAlnylam Pharmaceuticals$435.73-0.7%3.9189 of 5 stars2.85$403.92 -7.3%27Positive NewsAnalyst UpgradeAnalyst Revision2.60%EXELExelixis$37.50-0.6%4.9437 of 5 stars2.55$44.44 18.5%22Positive News2.57%NBIXNeurocrine Biosciences$123.83-0.9%4.9722 of 5 stars2.86$160.90 29.9%222.55%UTHRUnited Therapeutics$301.28-0.1%4.9594 of 5 stars2.69$379.69 26.0%13Insider Trade2.53%REGNRegeneron Pharmaceuticals$550.95-2.1%4.9122 of 5 stars2.75$826.91 50.1%24Positive NewsDividend AnnouncementAnalyst Forecast2.53%HALOHalozyme Therapeutics$62.59-0.5%4.8529 of 5 stars2.18$66.56 6.3%11Positive NewsEarnings Report2.53%INSMInsmed$111.50+1.8%3.8629 of 5 stars3.00$112.71 1.1%16Earnings ReportAnalyst ForecastAnalyst Revision2.46%VRTXVertex Pharmaceuticals$375.22+2.4%4.9249 of 5 stars2.56$497.10 32.5%27Earnings ReportAnalyst UpgradeAnalyst Revision2.44%AMGNAmgen$285.13-1.1%4.5525 of 5 stars2.33$303.76 6.5%21Earnings ReportAnalyst DowngradeAnalyst Revision2.42%BMRNBioMarin Pharmaceutical$56.64-1.2%4.994 of 5 stars2.75$93.17 64.5%24Analyst Upgrade2.39%GILDGilead Sciences$119.77+0.3%4.6365 of 5 stars2.80$114.82 -4.1%25Positive NewsEarnings ReportDividend AnnouncementAnalyst Upgrade2.39%ABBVAbbVie$197.27-0.4%4.6792 of 5 stars2.93$214.43 8.7%27Positive News2.38%INCYIncyte$78.71+0.4%4.7282 of 5 stars2.33$81.20 3.2%182.30%BBIOBridgeBio Pharma$47.40+1.8%4.735 of 5 stars3.00$61.35 29.4%17Earnings ReportAnalyst UpgradeAnalyst Revision2.27%BIIBBiogen$128.26-1.8%4.9076 of 5 stars2.34$185.63 44.7%32Analyst Revision2.19%EXASExact Sciences$40.78-0.5%4.6518 of 5 stars2.92$68.14 67.1%24News CoverageEarnings ReportAnalyst ForecastAnalyst Revision2.06%MDGLMadrigal Pharmaceuticals$347.99+0.7%3.7733 of 5 stars2.88$430.43 23.7%8Earnings ReportAnalyst Revision2.03%BPMCBlueprint Medicines$129.460.6347 of 5 stars2.11$130.00 0.4%18Positive News2.01%NTRANatera$157.09+3.4%4.142 of 5 stars3.06$193.87 23.4%17Earnings ReportAnalyst Forecast1.87%CRSPCRISPR Therapeutics$55.42+0.8%3.5543 of 5 stars2.50$71.60 29.2%16Earnings ReportAnalyst RevisionGap Down1.79%TGTXTG Therapeutics$26.36-1.3%3.9983 of 5 stars2.75$46.25 75.5%4Earnings ReportGap Down1.70%ROIVRoivant Sciences$11.12-3.3%1.9767 of 5 stars3.25$16.50 48.4%4News CoverageEarnings ReportGap Down1.59%CYTKCytokinetics$33.18-2.7%4.109 of 5 stars2.88$70.69 113.1%16Earnings ReportAnalyst Forecast1.52%IONSIonis Pharmaceuticals$40.85-1.9%4.4783 of 5 stars2.86$59.38 45.4%14Insider TradeAnalyst Revision This page (NYSEARCA:XBI) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access